OxFORD Asset Management LLP boosted its stake in Genpact Limited (NYSE:G) by 18.4% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 155,098 shares of the business services provider’s stock after buying an additional 24,108 shares during the quarter. OxFORD Asset Management LLP owned approximately 0.08% of Genpact worth $4,463,000 at the end of the most recent quarter.
A number of other hedge funds also recently made changes to their positions in the stock. Commerzbank Aktiengesellschaft FI boosted its stake in Genpact by 12.4% in the 3rd quarter. Commerzbank Aktiengesellschaft FI now owns 16,466 shares of the business services provider’s stock valued at $473,000 after buying an additional 1,816 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in Genpact by 2.0% in the third quarter. Dimensional Fund Advisors LP now owns 1,518,243 shares of the business services provider’s stock worth $43,649,000 after purchasing an additional 30,361 shares in the last quarter. Brown Advisory Inc. boosted its stake in Genpact by 2.0% in the third quarter. Brown Advisory Inc. now owns 12,598,190 shares of the business services provider’s stock worth $362,198,000 after purchasing an additional 247,088 shares in the last quarter. BB&T Securities LLC boosted its stake in Genpact by 5.9% in the third quarter. BB&T Securities LLC now owns 61,344 shares of the business services provider’s stock worth $1,763,000 after purchasing an additional 3,438 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. boosted its stake in Genpact by 3.7% in the third quarter. Schwab Charles Investment Management Inc. now owns 845,327 shares of the business services provider’s stock worth $24,304,000 after purchasing an additional 30,369 shares in the last quarter. 91.16% of the stock is currently owned by institutional investors and hedge funds.
Genpact Limited (NYSE:G) traded down $0.21 during midday trading on Thursday, reaching $31.95. The company had a trading volume of 1,304,400 shares, compared to its average volume of 1,040,368. The company has a market capitalization of $6,208.24, a P/E ratio of 20.88, a PEG ratio of 2.20 and a beta of 0.58. The company has a quick ratio of 1.65, a current ratio of 1.65 and a debt-to-equity ratio of 0.77. Genpact Limited has a fifty-two week low of $23.34 and a fifty-two week high of $32.51.
Genpact (NYSE:G) last released its quarterly earnings data on Tuesday, November 7th. The business services provider reported $0.46 EPS for the quarter, beating analysts’ consensus estimates of $0.36 by $0.10. The business had revenue of $708.82 million during the quarter, compared to the consensus estimate of $685.25 million. Genpact had a return on equity of 23.86% and a net margin of 10.18%. The firm’s revenue was up 9.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.37 earnings per share. equities research analysts predict that Genpact Limited will post 1.47 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 20th. Investors of record on Friday, December 8th will be issued a $0.06 dividend. The ex-dividend date of this dividend is Thursday, December 7th. This represents a $0.24 dividend on an annualized basis and a yield of 0.75%. Genpact’s dividend payout ratio is presently 17.39%.
A number of research firms have commented on G. Cowen set a $33.00 price objective on Genpact and gave the stock a “buy” rating in a research note on Tuesday, August 15th. Robert W. Baird restated an “outperform” rating and set a $34.00 target price on shares of Genpact in a research report on Wednesday, August 16th. BidaskClub downgraded Genpact from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, August 16th. Wedbush restated an “outperform” rating and set a $33.00 target price on shares of Genpact in a research report on Wednesday, August 9th. Finally, Zacks Investment Research upgraded Genpact from a “sell” rating to a “hold” rating and set a $35.00 target price for the company in a research report on Friday, November 10th. Three analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $33.38.
In other news, insider Mohit Thukral sold 25,000 shares of the company’s stock in a transaction dated Tuesday, November 28th. The stock was sold at an average price of $32.25, for a total transaction of $806,250.00. Following the completion of the transaction, the insider now directly owns 85,305 shares of the company’s stock, valued at $2,751,086.25. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Private Ltd Gic sold 1,499,806 shares of the company’s stock in a transaction dated Monday, November 20th. The stock was sold at an average price of $30.26, for a total value of $45,384,129.56. The disclosure for this sale can be found here. Insiders sold 1,575,051 shares of company stock valued at $47,739,747 in the last quarter. 1.41% of the stock is currently owned by corporate insiders.
Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.
Receive News & Ratings for Genpact Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact Limited and related companies with MarketBeat.com's FREE daily email newsletter.